MedCap AB

66
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
469.00
3 (0.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
MedCap AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
289.00
261.00
222.00
152.00
117.00
81.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
4.00
71.00
-69.00
-146.00
-55.00
-6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
342.00
360.00
228.00
85.00
116.00
115.00
Cash Flow from Investing Activities
-391.00
-128.00
-152.00
-56.00
-64.00
-131.00
Cash Flow from Financing Activities
52.00
-46.00
-119.00
61.00
-64.00
144.00
Net Cash Inflow / Outflow
0.00
182.00
-48.00
96.00
-6.00
126.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-3.00
-3.00
-4.00
5.00
5.00
-2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of MedCap AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
289
100.137
189.00
188.60%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
4.8
-61.699
65.00
107.78%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
342.7
79.795
263.00
329.48%
Cash Flow from Investing Activities
-391.3
-134.251
-257.00
-191.47%
Cash Flow from Financing Activities
52.3
-259.675
311.00
120.14%
Net Cash Inflow / Outflow
0.3
-351.73
351.00
100.09%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-3.4
-37.599
34.00
90.96%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -4.81% vs 57.89% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
342.70
360.00
-4.81%